A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

By afschroeder • August 31, 2025

Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess L, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Demoruelle MK, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM. A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis. Arthritis Rheumatol. 2025 Aug 29. doi: 10.1002/art.43366. Epub ahead of print. PMID: 40884017.

Tags: Publications, Rheumatology

CMV Infection after Lung Transplant: incidence, risk factors and management in a multi-center cohort

Snyder LD, Weber JM, Avery R, Neely ML, Robien MA, Schaenman J, Tsuang WM, Weigt SS, Kumar D. CMV Infection after Lung Transplant: incidence, risk[...]

Metabolic and Glycemic Effects of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta-Analysis of Randomised Clinical Trials

Hageen AW, Gadelmawla AF, Saleh AO, Mohamed MR, Abdallfatah A, Elsekhary A, El-Nemr AF, Eladawi S, Maihoub O, Abdulhay H, Turkmani M, Abdelazeem B, Fonarow[...]

Cerebriform Ridges on the Scalp Signaling a Tumor in the Brain

Park A, Kenney S, Kellogg C, Castillo JR, Bergheim T. Cerebriform Ridges on the Scalp Signaling a Tumor in the Brain. Perm J. 2026 Jul[...]